Integrated Filing — IndAS



General information about company

Scrip Code 532851
NSE Symbol INSECTICID
MSEI Symbol NA
ISIN INE070I01018
Name of company Insecticides (India) Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 05-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 25-09-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Agro-Chemicals
Start date and time of board meeting 05-11-2026   13:00:00
End date and time of board meeting 05-11-2026   15:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 10-02-2025
Indicate Company website link for updated RPT policy of the Company https://insecticidesindia.com/wp-content/uploads/2025/05/Revised-Related-Party-Transaction-Policy-10022025.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NIL



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 68,017.57 1,29,665.79
Other income (88.49) 373.87
Total income 67,929.08 1,30,039.66
2 Expenses
(a) Cost of materials consumed 41,081.23 79,723.21
(b) Purchases of stock-in-trade 6,582.70 14,253.53
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (1,331.40) (4,721.60)
(d) Employee benefit expense 5,130.12 9,628.46
(e) Finance costs 640.52 1,105.50
(f) Depreciation, depletion and amortisation expense 972.39 1,931.66
(f) Other Expenses
1 Other Expenses 8,058.93 15,697.84
Total other expenses 8,058.93 15,697.84
Total expenses 61,134.49 1,17,618.60
3 Total profit before exceptional items and tax 6,794.59 12,421.06
4 Exceptional items 0.00 0.00
5 Total profit before tax 6,794.59 12,421.06
6 Tax expense
7 Current tax 1,842.20 3,416.47
8 Deferred tax (105.20) (236.05)
9 Total tax expenses 1,737.00 3,180.42
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 5,057.59 9,240.64
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 5,057.59 9,240.64
17 Other comprehensive income net of taxes 136.54 (22.69)
18 Total Comprehensive Income for the period 5,194.13 9,217.95
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 2,909.78 2,909.78
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 17.38 31.76
Diluted earnings (loss) per share from continuing operations 17.38 31.76
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 17.38 31.76
Diluted earnings (loss) per share from continuing and discontinued operations 17.38 31.76
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 29,895.71
Capital work-in-progress 15,910.48
Investment property 97.47
Goodwill 4,458.55
Other intangible assets 717.98
Intangible assets under development 1,325.67
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 1,819.27
Non-current financial assets
Non-current investments 1,261.54
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Other financial assets 318.17
Total of other non-current financial assets 318.17
Total non-current financial assets 1,579.71
Deferred tax assets (net) 477.40
Other non-current assets
1 Other non-current assets 2,680.39
Total of other non-current assets 2,680.39
Total non-current assets 58,962.63
2 Current assets
Inventories 77,549.61
Current financial asset
Current investments 0.00
Trade receivables, current 73,052.75
Cash and cash equivalents 3,557.05
Bank balance other than cash and cash equivalents 128.31
Loans, current 16.34
Other current financial assets
Total of other current financial assets 888.84
Total current financial assets 77,643.29
Current tax assets (net) 0.00
Other current assets
1 Other current assets 5,077.85
Total of other current assets 5,077.85
Total current assets 1,60,270.75
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 2,19,233.38
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 2,909.78
Other equity 1,27,708.53
Total equity attributable to owners of parent 1,30,618.31
Non controlling interest
Total equity 1,30,618.31
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 1,384.65
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other non-current financial liabilities 743.83
Total of other non-current financial liabilities 743.83
Total non-current financial liabilities 2,128.48
Provisions, non-current 288.59
Deferred tax liabilities (net) 698.31
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 3,115.38
Current liabilities
Current financial liabilities
Borrowings, current 21,897.69
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 6,113.41
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 45,650.15
Total Trade payable 51,763.56
Other current financial liabilities
1 Other financial liabilities 6,983.29
Total of other current financial liabilities 6,983.29
Total current financial liabilities 80,644.54
Other current liabilities 3,880.44
1 Other current liabilities 3,880.44
Total of other current liabilities 3,880.44
Provisions, current 618.15
Current tax liabilities (Net) 356.56
Deferred government grants, Current 0.00
Total current liabilities 85,499.69
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 88,615.07
Total equity and liabilites 2,19,233.38
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Changes in fair value of FVTOCI equity instruments 208.49 31.39
2 Remeasurement of net defined benefit plans (31.25) (62.50)
3 Income tax relating to these items (40.70) 8.42
Total Amount of items that will not be reclassified to profit and loss 136.54 (22.69)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 136.54 (22.69)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 12,421.06
Adjustments for reconcile profit (loss)
Adjustments for finance costs 1,105.50
Adjustments for decrease (increase) in inventories 718.29
Adjustments for decrease (increase) in trade receivables, current (24,346.01)
Adjustments for decrease (increase) in trade receivables, non-current 10.53
Adjustments for decrease (increase) in other current assets 2,302.10
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.03
Adjustments for other financial assets, current 3.42
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 7,699.82
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (8,135.61)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 1,931.66
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 137.50
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 2,210.06
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 10.89
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (906.95)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (17,280.55)
Net cash flows from (used in) operations (4,859.49)
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 3,059.91
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (7,919.40)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 70.66
Purchase of property, plant and equipment 5,500.46
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets (0.51)
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 10.91
Interest received 10.89
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities (5,408.51)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 10,108.99
Repayments of borrowings 672.24
Payments of lease liabilities 186.69
Dividends paid 0.00
Interest paid 1,077.61
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 8,172.45
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (5,155.46)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (5,155.46)
Cash and cash equivalents cash flow statement at beginning of period 8,712.51
Cash and cash equivalents cash flow statement at end of period 3,557.05





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Insecticides (India) Limited Hari Chand Aggarwal Chairman / KMP Remuneration 0.00 No adverse Remark 160.15 11.30 72.23
2 Insecticides (India) Limited Rajesh Kumar Aggarwal Managing Director / KMP Remuneration 0.00 No adverse Remark 162.66 11.49 14.55
3 Insecticides (India) Limited Nikunj Aggarwal Whole-time Director / KMP Remuneration 0.00 No adverse Remark 7.99 5.06 0.00
4 Insecticides (India) Limited Anil Kumar Goyal Whole-time Director / KMP Remuneration 0.00 No adverse Remark 7.64 1.50 2.07
5 Insecticides (India) Limited Sandeep Aggarwal Chief Financial Officer / KMP Remuneration 0.00 No adverse Remark 33.24 5.04 9.73
6 Insecticides (India) Limited Sandeep Kumar Company Secreatary / KMP Remuneration 0.00 No adverse Remark 19.40 4.18 5.93
7 Insecticides (India) Limited Sanskar Aggarwal Whole-time Director/KMP Remuneration 0.00 No adverse Remark 26.93 2.99 5.60
8 Insecticides (India) Limited Sanjeev Aggarwal Relative of KMP Remuneration 0.00 No adverse Remark 23.43 3.86 8.01
9 Insecticides (India) Limited Praveen Gupta Independent Director Any other transaction sitting fees 0.00 No adverse Remark 6.15 0.00 0.00
10 Insecticides (India) Limited Anil Kumar Bhatia Independent Director Any other transaction sitting fees 0.00 No adverse Remark 5.80 0.00 0.00
11 Insecticides (India) Limited Shyam Lal Bansal Independent Director Any other transaction sitting fees 0.00 No adverse Remark 6.85 0.00 0.00
12 Insecticides (India) Limited Supratim Bandyopadhyay Independent Director Any other transaction sitting fees 0.00 No adverse Remark 6.15 0.00 0.00
13 Insecticides (India) Limited Sonia Aggarwal Relative of KMP Any other transaction sitting fees 0.00 No adverse Remark 4.50 0.84 0.84
14 Insecticides (India) Limited Anju Aggarwal Relative of KMP Remuneration 0.00 No adverse Remark 8.95 2.37 2.80
15 Insecticides (India) Limited Pushpa Aggarwal Relative of KMP Any other transaction Rent paid 69.00 No adverse Remark 5.82 0.00 0.00
16 Insecticides (India) Limited ISEC Organics Limited Directors and Directors relatives holding more than 2% Any other transaction Rent Paid 1,000.00 No adverse Remark 90.07 0.00 0.00
17 Insecticides (India) Limited ISEC Organics Limited Directors and Directors relatives holding more than 2% Any other transaction Advance Given 1,000.00 No adverse Remark 0.00 203.26 203.26
18 Insecticides (India) Limited IIL Foundation Trust in which Promoter is a Trustee Any other transaction Corporate Social Responsibility 344.00 No adverse Remark 172.00 0.00 0.00
19 Insecticides (India) Limited IIL Biologicals Limited Wholly-owned Subsidiary Purchase of goods or services 2,000.00 No adverse Remark 415.56 84.26 222.58
20 Insecticides (India) Limited IIL Biologicals Limited Wholly-owned Subsidiary Any other transaction Rental Income 2,000.00 No adverse Remark 6.50 0.00 0.00
21 Insecticides (India) Limited IIL Biologicals Limited Wholly-owned Subsidiary Sale of goods or services 2,000.00 No adverse Remark 85.43 39.99 86.44
22 Insecticides (India) Limited IIL Biologicals Limited Wholly-owned Subsidiary Any other transaction Security Deposit Payable 2,000.00 No adverse Remark 0.00 2.63 2.63
23 Insecticides (India) Limited Kaeros Research Ltd. formerly known as Kaeros Research P Ltd. Wholly-owned Subsidiary Purchase of goods or services 30,000.00 No adverse Remark 6,712.57 2,534.24 441.26
24 Insecticides (India) Limited Kaeros Research Ltd. formerly known as Kaeros Research P Ltd. Wholly-owned Subsidiary Any other transaction Rental Income 30,000.00 No adverse Remark 23.46 0.00 0.00
25 Insecticides (India) Limited Kaeros Research Ltd. formerly known as Kaeros Research P Ltd. Wholly-owned Subsidiary Sale of goods or services 30,000.00 No adverse Remark 6,585.82 367.09 5,801.75
26 Insecticides (India) Limited Kaeros Research Ltd. formerly known as Kaeros Research P Ltd. Wholly-owned Subsidiary Any other transaction Expense Reimbursement 30,000.00 No adverse Remark 9.32 0.00 0.00
27 Insecticides (India) Limited Kaeros Research Ltd. formerly known as Kaeros Research P Ltd. Wholly-owned Subsidiary Advance 30,000.00 No adverse Remark 460.00 0.00 0.00
28 Insecticides (India) Limited Kaeros Research Ltd. formerly known as Kaeros Research P Ltd. Wholly-owned Subsidiary Any other transaction Advance received back 30,000.00 No adverse Remark 460.00 0.00 0.00
29 Insecticides (India) Limited Kaeros Research Ltd. formerly known as Kaeros Research P Ltd. Wholly-owned Subsidiary Any other transaction Security Deposit Payable 30,000.00 No adverse Remark 0.00 9.74 9.74
30 Insecticides (India) Limited Valve & Pneumatics Directors Relatives holding more than 2% Purchase of goods or services 600.00 No adverse Remark 0.00 0.00 0.00
31 Insecticides (India) Limited Valve & Pneumatics Directors Relatives holding more than 2% Sale of goods or services 600.00 No adverse Remark 0.00 0.00 0.00
32 Insecticides (India) Limited OAT & IIL India Laboratories Private Limited Joint Venture (Enterprises over which the Company exercises joint control) Any other transaction R & D Expenses 1,720.00 No adverse Remark 515.28 0.00 0.00
33 Insecticides (India) Limited OAT & IIL India Laboratories Private Limited Joint Venture (Enterprises over which the Company exercises joint control) Any other transaction Deputation Fee Income 1,720.00 No adverse Remark 29.54 0.00 0.00
34 Insecticides (India) Limited OAT & IIL India Laboratories Private Limited Joint Venture (Enterprises over which the Company exercises joint control) Any other transaction Job Work Income 1,720.00 No adverse Remark 24.92 8.91 42.50
35 Insecticides (India) Limited OAT & IIL India Laboratories Private Limited Joint Venture (Enterprises over which the Company exercises joint control) Purchase of goods or services 1,720.00 No adverse Remark 671.07 0.00 365.73
36 Insecticides (India) Limited Vinod Metal Industries Directors Relatives holding more than 2% Purchase of goods or services 600.00 No adverse Remark 139.96 91.88 94.64
37 Insecticides (India) Limited Indogulf Cropsciences Ltd. Directors Relatives holding more than 2% Purchase of goods or services 1,500.00 No adverse Remark 285.41 0.00 116.54
38 Insecticides (India) Limited Indogulf Cropsciences Ltd. Directors Relatives holding more than 2% Sale of goods or services 1,500.00 No adverse Remark 157.22 81.73 0.00
39 Insecticides (India) Limited Crystal Crop Protection Ltd. Directors Relatives holding more than 2% Purchase of goods or services 5,000.00 No adverse Remark 287.92 0.00 287.73
40 Insecticides (India) Limited Crystal Crop Protection Ltd. Directors Relatives holding more than 2% Sale of goods or services 5,000.00 No adverse Remark 772.15 942.45 673.64
41 Insecticides (India) Limited HPM Chemicals and Fertilizers Ltd. Directors Relatives holding more than 2% Purchase of goods or services 2,500.00 No adverse Remark 663.00 884.25 688.67
42 Insecticides (India) Limited HPM Chemicals and Fertilizers Ltd. Directors Relatives holding more than 2% Sale of goods or services 2,500.00 No adverse Remark 409.14 208.98 412.07
43 Insecticides (India) Limited Crop Care Federation of India KMP is the Director Any other transaction Subscription Fee 50.00 No adverse Remark 11.80 0.00 0.29
44 Insecticides (India) Limited Crop Care Federation of India KMP is the Director Any other transaction Adv Exp 50.00 No adverse Remark 0.30 0.00 0.00
Total value of transaction during the reporting period 19,474.10